{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:36:16Z","timestamp":1793716576178,"version":"4.6.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30AG13846; supplement 0572063345"],"award-info":[{"award-number":["P30AG13846; supplement 0572063345"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG057902"],"award-info":[{"award-number":["R01AG057902"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG061028"],"award-info":[{"award-number":["R01AG061028"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["K23AG046377"],"award-info":[{"award-number":["K23AG046377"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG1649"],"award-info":[{"award-number":["R01AG1649"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG062348"],"award-info":[{"award-number":["R01AG062348"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R21HD089088"],"award-info":[{"award-number":["R21HD089088"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["F32NS096803"],"award-info":[{"award-number":["F32NS096803"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["F32AG056098"],"award-info":[{"award-number":["F32AG056098"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U01NS086659"],"award-info":[{"award-number":["U01NS086659"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U01NS093334"],"award-info":[{"award-number":["U01NS093334"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U54NS115266"],"award-info":[{"award-number":["U54NS115266"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS078337"],"award-info":[{"award-number":["R01NS078337"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R56NS078337"],"award-info":[{"award-number":["R56NS078337"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["K23NS102399"],"award-info":[{"award-number":["K23NS102399"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["1UL1TR001430"],"award-info":[{"award-number":["1UL1TR001430"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01 CX001135"],"award-info":[{"award-number":["I01 CX001135"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["CSP 501"],"award-info":[{"award-number":["CSP 501"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["B6796-C"],"award-info":[{"award-number":["B6796-C"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01-CX001038"],"award-info":[{"award-number":["I01-CX001038"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-13-2-0095"],"award-info":[{"award-number":["W81XWH-13-2-0095"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-13-2-0064"],"award-info":[{"award-number":["W81XWH-13-2-0064"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH1810580"],"award-info":[{"award-number":["W81XWH1810580"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["PRARP-13267017"],"award-info":[{"award-number":["PRARP-13267017"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["NIRG-15-362697"],"award-info":[{"award-number":["NIRG-15-362697"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["NIRG-305779"],"award-info":[{"award-number":["NIRG-305779"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005636","name":"National Operating Committee on Standards for Athletic Equipment","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005636","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020804","name":"Nick and Lynn Buoniconti Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100020804","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100018097","name":"Concussion Legacy Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018097","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Andlinger Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease characterized by hyperphosphorylated tau (p-tau) accumulation. The clinical features associated with CTE pathology are unclear. In brain donors with autopsy-confirmed CTE, we investigated the association of CTE p-tau pathology density and location with cognitive, functional, and neuropsychiatric symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In 364 brain donors with autopsy confirmed CTE, semi-quantitative p-tau severity (range: 0\u20133) was assessed in 10 cortical and subcortical regions. We summed ratings across regions to form a p-tau severity global composite (range: 0\u201330). Informants completed standardized scales of cognition (Cognitive Difficulties Scale, CDS; BRIEF-A Metacognition Index, MI), activities of daily living (Functional Activities Questionnaire), neurobehavioral dysregulation (BRIEF-A Behavioral Regulation Index, BRI; Barratt Impulsiveness Scale, BIS-11), aggression (Brown-Goodwin Aggression Scale), depression (Geriatric Depression Scale-15, GDS-15), and apathy (Apathy Evaluation Scale, AES). Ordinary least squares regression models examined associations between global and regional p-tau severity (separate models for each region) with each clinical scale, adjusting for age at death, racial identity, education level, and history of hypertension, obstructive sleep apnea, and substance use treatment. Ridge regression models that incorporated p-tau severity across all regions in the same model assessed which regions showed independent effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The sample was predominantly American football players (333; 91.2%); 140 (38.5%) had low CTE and 224 (61.5%) had high CTE. Global p-tau severity was associated with higher (i.e., worse) scores on the cognitive and functional scales: MI (\n                      <jats:inline-formula>\n                        <jats:alternatives>\n                          <jats:tex-math>$$\\beta$$<\/jats:tex-math>\n                          <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                            <mml:mi>\u03b2<\/mml:mi>\n                          <\/mml:math>\n                        <\/jats:alternatives>\n                      <\/jats:inline-formula>\n                      <jats:sub>standardized<\/jats:sub>\n                      \u2009=\u20090.02, 95%CI\u2009=\u20090.01\u20130.04), CDS (\n                      <jats:inline-formula>\n                        <jats:alternatives>\n                          <jats:tex-math>$$\\beta$$<\/jats:tex-math>\n                          <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                            <mml:mi>\u03b2<\/mml:mi>\n                          <\/mml:math>\n                        <\/jats:alternatives>\n                      <\/jats:inline-formula>\n                      <jats:sub>standardized<\/jats:sub>\n                      \u2009=\u20090.02, 95%CI\u2009=\u20090.01\u20130.04), and FAQ (\n                      <jats:inline-formula>\n                        <jats:alternatives>\n                          <jats:tex-math>$$\\beta$$<\/jats:tex-math>\n                          <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                            <mml:mi>\u03b2<\/mml:mi>\n                          <\/mml:math>\n                        <\/jats:alternatives>\n                      <\/jats:inline-formula>\n                      <jats:sub>standardized<\/jats:sub>\n                      \u2009=\u20090.03, 95%CI\u2009=\u20090.01\u20130.04). After false-discovery rate correction, p-tau severity in the frontal, inferior parietal, and superior temporal cortex, and the amygdala was associated with higher CDS (\n                      <jats:inline-formula>\n                        <jats:alternatives>\n                          <jats:tex-math>$$\\beta$$<\/jats:tex-math>\n                          <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                            <mml:mi>\u03b2<\/mml:mi>\n                          <\/mml:math>\n                        <\/jats:alternatives>\n                      <\/jats:inline-formula>\n                      s\n                      <jats:sub>standardized<\/jats:sub>\n                      \u2009=\u20090.17\u20130.29, ps\u2009&lt;\u20090.01) and FAQ (\n                      <jats:inline-formula>\n                        <jats:alternatives>\n                          <jats:tex-math>$$\\beta$$<\/jats:tex-math>\n                          <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                            <mml:mi>\u03b2<\/mml:mi>\n                          <\/mml:math>\n                        <\/jats:alternatives>\n                      <\/jats:inline-formula>\n                      s\n                      <jats:sub>standardized<\/jats:sub>\n                      \u2009=\u20090.21\u20130.26, ps\u2009&lt;\u20090.01); frontal and inferior parietal cortex was associated with higher MI (\n                      <jats:inline-formula>\n                        <jats:alternatives>\n                          <jats:tex-math>$$\\beta$$<\/jats:tex-math>\n                          <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                            <mml:mi>\u03b2<\/mml:mi>\n                          <\/mml:math>\n                        <\/jats:alternatives>\n                      <\/jats:inline-formula>\n                      s\n                      <jats:sub>standardized<\/jats:sub>\n                      \u2009=\u20090.21\u20130.29, ps\u2009&lt;\u20090.05); frontal cortex was associated with higher BRI (\n                      <jats:inline-formula>\n                        <jats:alternatives>\n                          <jats:tex-math>$$\\beta$$<\/jats:tex-math>\n                          <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                            <mml:mi>\u03b2<\/mml:mi>\n                          <\/mml:math>\n                        <\/jats:alternatives>\n                      <\/jats:inline-formula>\n                      <jats:sub>standardized<\/jats:sub>\n                      \u2009=\u20090.21,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01). Regions with effects independent of other regions included frontal cortex (CDS, MI, FAQ, BRI), inferior parietal cortex (CDS) and amygdala (FAQ). P-tau explained 13\u201349% of variance in cognitive and functional scales and 6\u201314% of variance in neuropsychiatric scales.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Accumulation of p-tau aggregates, especially in the frontal cortex, are associated with cognitive, functional, and certain neurobehavioral symptoms in CTE.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13024-023-00697-2","type":"journal-article","created":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T20:02:16Z","timestamp":1707163336000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Cognitive, functional, and neuropsychiatric correlates of regional tau pathology in autopsy-confirmed chronic traumatic encephalopathy"],"prefix":"10.1186","volume":"19","author":[{"given":"Michael L.","family":"Alosco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micaela","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carter","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farwa","family":"Faheem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yorghos","family":"Tripodis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eukyung","family":"Yhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Baucom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Palmisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Dams-O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Crary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee E.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas I.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigid","family":"Dwyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel H.","family":"Daneshvar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Nowinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Cantu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil W.","family":"Kowall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor E.","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand Russell","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thor D.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann C.","family":"McKee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1438-5442","authenticated-orcid":false,"given":"Jesse","family":"Mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,6]]},"reference":[{"issue":"1","key":"697_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/bpa.12757.PMC6916416","volume":"30","author":"KF Bieniek","year":"2020","unstructured":"Bieniek KF, Blessing MM, Heckman MG, et al. Association between contact sports participation and chronic traumatic encephalopathy: a retrospective cohort study. Brain Pathol. 2020;30(1):63\u201374. https:\/\/doi.org\/10.1111\/bpa.12757.PMC6916416.","journal-title":"Brain Pathol"},{"issue":"1","key":"697_CR2","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/ana.25611.PMC6973077","volume":"87","author":"J Mez","year":"2020","unstructured":"Mez J, Daneshvar DH, Abdolmohammadi B, et al. Duration of American Football Play and Chronic Traumatic Encephalopathy. Ann Neurol. 2020;87(1):116\u201331. https:\/\/doi.org\/10.1002\/ana.25611.PMC6973077.","journal-title":"Ann Neurol"},{"key":"697_CR3","doi-asserted-by":"publisher","first-page":"938163","DOI":"10.3389\/fneur.2022.938163.PMC9355594","volume":"13","author":"CJ Nowinski","year":"2022","unstructured":"Nowinski CJ, Bureau SC, Buckland ME, et al. Applying the Bradford Hill Criteria for Causation to Repetitive Head Impacts and Chronic Traumatic Encephalopathy. Front Neurol. 2022;13:938163. https:\/\/doi.org\/10.3389\/fneur.2022.938163.PMC9355594.","journal-title":"Front Neurol"},{"issue":"3","key":"697_CR4","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1093\/jnen\/nlab001.PMC7899277","volume":"80","author":"KF Bieniek","year":"2021","unstructured":"Bieniek KF, Cairns NJ, Crary JF, et al. The Second NINDS\/NIBIB Consensus Meeting to Define Neuropathological Criteria for the Diagnosis of Chronic Traumatic Encephalopathy. J Neuropathol Exp Neurol. 2021;80(3):210\u20139. https:\/\/doi.org\/10.1093\/jnen\/nlab001.PMC7899277.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"697_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00401-015-1515-z.PMC4698281","volume":"131","author":"AC McKee","year":"2016","unstructured":"McKee AC, Cairns NJ, Dickson DW, et al. The first NINDS\/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy. Acta Neuropathol. 2016;131(1):75\u201386. https:\/\/doi.org\/10.1007\/s00401-015-1515-z.PMC4698281.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"697_CR6","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00401-020-02197-9","volume":"140","author":"ML Alosco","year":"2020","unstructured":"Alosco ML, Cherry JD, Huber BR, et al. Characterizing tau deposition in chronic traumatic encephalopathy (CTE): utility of the McKee CTE staging scheme. Acta Neuropathol. 2020;140(4):495\u2013512. https:\/\/doi.org\/10.1007\/s00401-020-02197-9.","journal-title":"Acta Neuropathol"},{"issue":"Pt 1","key":"697_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/brain\/aws307.PMC3624697","volume":"136","author":"AC McKee","year":"2013","unstructured":"McKee AC, Stern RA, Nowinski CJ, et al. The spectrum of disease in chronic traumatic encephalopathy. Brain. 2013;136(Pt 1):43\u201364. https:\/\/doi.org\/10.1093\/brain\/aws307.PMC3624697.","journal-title":"Brain"},{"issue":"4","key":"697_CR8","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1001\/jama.2017.8334.PMC5807097","volume":"318","author":"J Mez","year":"2017","unstructured":"Mez J, Daneshvar DH, Kiernan PT, et al. Clinicopathological Evaluation of Chronic Traumatic Encephalopathy in Players of American Football. JAMA. 2017;318(4):360\u201370. https:\/\/doi.org\/10.1001\/jama.2017.8334.PMC5807097.","journal-title":"JAMA"},{"issue":"18","key":"697_CR9","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1212\/WNL.0000000000011850.PMC8166432","volume":"96","author":"DI Katz","year":"2021","unstructured":"Katz DI, Bernick C, Dodick DW, et al. National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome. Neurology. 2021;96(18):848\u201363. https:\/\/doi.org\/10.1212\/WNL.0000000000011850.PMC8166432.","journal-title":"Neurology"},{"key":"697_CR10","doi-asserted-by":"publisher","unstructured":"Mez J, Solomon TM, Daneshvar DH, et al. Assessing clinicopathological correlation in chronic traumatic encephalopathy: rationale and methods for the UNITE study. Alzheimers Res Ther. Oct 12 2015;7(1):62. https:\/\/doi.org\/10.1186\/s13195-015-0148-8. PMC4601147","DOI":"10.1186\/s13195-015-0148-8"},{"issue":"10","key":"697_CR11","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1002\/alz.12338.PMC8596795","volume":"17","author":"J Mez","year":"2021","unstructured":"Mez J, Alosco ML, Daneshvar DH, et al. Validity of the 2014 traumatic encephalopathy syndrome criteria for CTE pathology. Alzheimers Dement. 2021;17(10):1709\u201324. https:\/\/doi.org\/10.1002\/alz.12338.PMC8596795.","journal-title":"Alzheimers Dement"},{"issue":"5","key":"697_CR12","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13195-014-0068-z.PMC4288217","volume":"6","author":"PH Montenigro","year":"2014","unstructured":"Montenigro PH, Baugh CM, Daneshvar DH, et al. Clinical subtypes of chronic traumatic encephalopathy: literature review and proposed research diagnostic criteria for traumatic encephalopathy syndrome. Alzheimers Res Ther. 2014;6(5):68. https:\/\/doi.org\/10.1186\/s13195-014-0068-z.PMC4288217.","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"697_CR13","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1212\/WNL.0000000000002892","volume":"87","author":"H Cho","year":"2016","unstructured":"Cho H, Choi JY, Hwang MS, et al. Tau PET in Alzheimer disease and mild cognitive impairment. Neurology. 2016;87(4):375\u201383. https:\/\/doi.org\/10.1212\/WNL.0000000000002892.","journal-title":"Neurology"},{"issue":"1","key":"697_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00401-009-0532-1","volume":"118","author":"C Duyckaerts","year":"2009","unstructured":"Duyckaerts C, Delatour B, Potier MC. Classification and basic pathology of Alzheimer disease. Acta Neuropathol. 2009;118(1):5\u201336. https:\/\/doi.org\/10.1007\/s00401-009-0532-1.","journal-title":"Acta Neuropathol"},{"key":"697_CR15","doi-asserted-by":"publisher","unstructured":"La Joie R, Visani AV, Baker SL, et al. Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau-PET. Sci Transl Med. 2020;12(524). https:\/\/doi.org\/10.1126\/scitranslmed.aau5732.","DOI":"10.1126\/scitranslmed.aau5732"},{"issue":"Pt 5","key":"697_CR16","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1093\/brain\/awv050.PMC4407190","volume":"138","author":"ME Murray","year":"2015","unstructured":"Murray ME, Lowe VJ, Graff-Radford NR, et al. Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer\u2019s disease spectrum. Brain. 2015;138(Pt 5):1370\u201381. https:\/\/doi.org\/10.1093\/brain\/awv050.PMC4407190.","journal-title":"Brain"},{"issue":"5","key":"697_CR17","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7.PMC3560290","volume":"71","author":"PT Nelson","year":"2012","unstructured":"Nelson PT, Alafuzoff I, Bigio EH, et al. Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol. 2012;71(5):362\u201381. https:\/\/doi.org\/10.1097\/NEN.0b013e31825018f7.PMC3560290.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"Pt 5","key":"697_CR18","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1093\/brain\/aww027.PMC5006248","volume":"139","author":"R Ossenkoppele","year":"2016","unstructured":"Ossenkoppele R, Schonhaut DR, Scholl M, et al. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer\u2019s disease. Brain. 2016;139(Pt 5):1551\u201367. https:\/\/doi.org\/10.1093\/brain\/aww027.PMC5006248.","journal-title":"Brain."},{"issue":"1","key":"697_CR19","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1212\/WNL.0000000000011081.PMC7884976","volume":"96","author":"J Therriault","year":"2021","unstructured":"Therriault J, Pascoal TA, Savard M, et al. Topographic Distribution of Amyloid-beta, Tau, and Atrophy in Patients With Behavioral\/Dysexecutive Alzheimer Disease. Neurology. 2021;96(1):e81\u201392. https:\/\/doi.org\/10.1212\/WNL.0000000000011081.PMC7884976.","journal-title":"Neurology"},{"issue":"2","key":"697_CR20","doi-asserted-by":"publisher","first-page":"757","DOI":"10.3233\/JAD-170578.PMC6352915","volume":"67","author":"GA Marshall","year":"2019","unstructured":"Marshall GA, Gatchel JR, Donovan NJ, et al. Regional Tau Correlates of Instrumental Activities of Daily Living and Apathy in Mild Cognitive Impairment and Alzheimer\u2019s Disease Dementia. J Alzheimers Dis. 2019;67(2):757\u201368. https:\/\/doi.org\/10.3233\/JAD-170578.PMC6352915.","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"697_CR21","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2165\/11533100-000000000-00000.PMC2916644","volume":"24","author":"GD Rabinovici","year":"2010","unstructured":"Rabinovici GD, Miller BL. Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management. CNS Drugs. 2010;24(5):375\u201398. https:\/\/doi.org\/10.2165\/11533100-000000000-00000.PMC2916644.","journal-title":"CNS Drugs"},{"key":"697_CR22","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0072-9752(07)01233-X","volume":"89","author":"GD Rabinovici","year":"2008","unstructured":"Rabinovici GD, Rascovsky K, Miller BL. Frontotemporal lobar degeneration: clinical and pathologic overview. Handb Clin Neurol. 2008;89:343\u201364. https:\/\/doi.org\/10.1016\/S0072-9752(07)01233-X.","journal-title":"Handb Clin Neurol"},{"issue":"5","key":"697_CR23","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1007\/s11682-021-00456-1","volume":"15","author":"E Ratti","year":"2021","unstructured":"Ratti E, Domoto-Reilly K, Caso C, et al. Regional prefrontal cortical atrophy predicts specific cognitive-behavioral symptoms in ALS-FTD. Brain Imaging Behav. 2021;15(5):2540\u201351. https:\/\/doi.org\/10.1007\/s11682-021-00456-1.","journal-title":"Brain Imaging Behav"},{"issue":"11","key":"697_CR24","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1001\/jamaneurol.2019.2244.PMC6686769","volume":"76","author":"ML Alosco","year":"2019","unstructured":"Alosco ML, Stein TD, Tripodis Y, et al. Association of White Matter Rarefaction, Arteriolosclerosis, and Tau With Dementia in Chronic Traumatic Encephalopathy. JAMA Neurol. 2019;76(11):1298\u2013308. https:\/\/doi.org\/10.1001\/jamaneurol.2019.2244.PMC6686769.","journal-title":"JAMA Neurol"},{"key":"697_CR25","doi-asserted-by":"publisher","unstructured":"Cherry JD, Tripodis Y, Alvarez VE, et al. Microglial neuroinflammation contributes to tau accumulation in chronic traumatic encephalopathy. Acta Neuropathol Commun. Oct 28 2016;4(1):112. https:\/\/doi.org\/10.1186\/s40478-016-0382-8. PMC5084333","DOI":"10.1186\/s40478-016-0382-8"},{"issue":"7","key":"697_CR26","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/NEN.0b013e31817d751c.PMC2761710","volume":"67","author":"EH Bigio","year":"2008","unstructured":"Bigio EH. Update on recent molecular and genetic advances in frontotemporal lobar degeneration. J Neuropathol Exp Neurol. 2008;67(7):635\u201348. https:\/\/doi.org\/10.1097\/NEN.0b013e31817d751c.PMC2761710.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"697_CR27","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2353\/ajpath.2007.070182.PMC1941578","volume":"171","author":"NJ Cairns","year":"2007","unstructured":"Cairns NJ, Neumann M, Bigio EH, et al. TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. Am J Pathol. 2007;171(1):227\u201340. https:\/\/doi.org\/10.2353\/ajpath.2007.070182.PMC1941578.","journal-title":"Am J Pathol"},{"issue":"11","key":"697_CR28","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1097\/00005072-199911000-00004","volume":"58","author":"KL Newell","year":"1999","unstructured":"Newell KL, Hyman BT, Growdon JH, Hedley-Whyte ET. Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease. J Neuropathol Exp Neurol. 1999;58(11):1147\u201355. https:\/\/doi.org\/10.1097\/00005072-199911000-00004.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3 Suppl","key":"697_CR29","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3233\/jad-2006-9s347","volume":"9","author":"IG McKeith","year":"2006","unstructured":"McKeith IG. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. J Alzheimers Dis. 2006;9(3 Suppl):417\u201323. https:\/\/doi.org\/10.3233\/jad-2006-9s347.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"697_CR30","first-page":"1","volume":"3","author":"DW Dickson","year":"2009","unstructured":"Dickson DW. Neuropathology of non-Alzheimer degenerative disorders. Int J Clin Exp Pathol. 2009;3(1):1\u201323.","journal-title":"Int J Clin Exp Pathol"},{"issue":"3","key":"697_CR31","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/jnnp.33.3.338.PMC493478","volume":"33","author":"B Brownell","year":"1970","unstructured":"Brownell B, Oppenheimer DR, Hughes JT. The central nervous system in motor neurone disease. J Neurol Neurosurg Psychiatry. 1970;33(3):338\u201357. https:\/\/doi.org\/10.1136\/jnnp.33.3.338.PMC493478.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"697_CR32","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s00401-014-1349-0.PMC4257842","volume":"128","author":"JF Crary","year":"2014","unstructured":"Crary JF, Trojanowski JQ, Schneider JA, et al. Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol. 2014;128(6):755\u201366. https:\/\/doi.org\/10.1007\/s00401-014-1349-0.PMC4257842.","journal-title":"Acta Neuropathol"},{"issue":"8","key":"697_CR33","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1093\/jnen\/nly049.PMC6044344","volume":"77","author":"LM Besser","year":"2018","unstructured":"Besser LM, Kukull WA, Teylan MA, et al. The Revised National Alzheimer\u2019s Coordinating Center\u2019s Neuropathology Form-Available Data and New Analyses. J Neuropathol Exp Neurol. 2018;77(8):717\u201326. https:\/\/doi.org\/10.1093\/jnen\/nly049.PMC6044344.","journal-title":"J Neuropathol Exp Neurol."},{"key":"697_CR34","volume-title":"Behavior rating inventory of executive function: BRIEF","author":"GA Gioia","year":"2000","unstructured":"Gioia GA, Isquith PK, Guy SC, Kenworthy L. Behavior rating inventory of executive function: BRIEF. Psychological Assessment Resources Odessa: FL; 2000."},{"issue":"4","key":"697_CR35","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jalz.2009.06.005.PMC3078579","volume":"6","author":"OC Okonkwo","year":"2010","unstructured":"Okonkwo OC, Spitznagel MB, Alosco ML, Tremont G. Associations among measures of awareness of cognitive deficits in dementia. Alzheimers Dement. 2010;6(4):312\u20138. https:\/\/doi.org\/10.1016\/j.jalz.2009.06.005.PMC3078579.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"697_CR36","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1017\/S1355617720001058","volume":"27","author":"CS Gass","year":"2021","unstructured":"Gass CS, Patten B, Penate A, Rhodes A. The Cognitive Difficulties Scale (CDS): Psychometric Characteristics in a Clinical Referral Sample. J Int Neuropsychol Soc. 2021;27(4):351\u201364. https:\/\/doi.org\/10.1017\/S1355617720001058.","journal-title":"J Int Neuropsychol Soc"},{"issue":"7","key":"697_CR37","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/gps.930080712","volume":"8","author":"C Derouesne","year":"1993","unstructured":"Derouesne C, Dealberto M, Boyer P, et al. Empirical evaluation of the \u2018Cognitive Difficulties Scale\u2019for assessment of memory complaints in general practice: A study of 1628 cognitively normal subjects aged 45\u201375 years. Int J Geriatr Psychiatry. 1993;8(7):599\u2013607.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"3","key":"697_CR38","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/geronj\/37.3.323","volume":"37","author":"RI Pfeffer","year":"1982","unstructured":"Pfeffer RI, Kurosaki TT, Harrah CH Jr, Chance JM, Filos S. Measurement of functional activities in older adults in the community. J Gerontol. 1982;37(3):323\u20139. https:\/\/doi.org\/10.1093\/geronj\/37.3.323.","journal-title":"J Gerontol"},{"key":"697_CR39","unstructured":"BIS11. Accessed 28 Apr. 2021, http:\/\/www.impulsivity.org\/measurement\/bis11"},{"issue":"2","key":"697_CR40","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0165-1781(79)90053-2","volume":"1","author":"GL Brown","year":"1979","unstructured":"Brown GL, Goodwin FK, Ballenger JC, Goyer PF, Major LF. Aggression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatry Res. 1979;1(2):131\u20139. https:\/\/doi.org\/10.1016\/0165-1781(79)90053-2.","journal-title":"Psychiatry Res"},{"issue":"1","key":"697_CR41","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0022-3956(82)90033-4","volume":"17","author":"JA Yesavage","year":"1982","unstructured":"Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982;17(1):37\u201349. https:\/\/doi.org\/10.1016\/0022-3956(82)90033-4.","journal-title":"J Psychiatr Res"},{"key":"697_CR42","doi-asserted-by":"publisher","unstructured":"Sheikh JI, Yesavage JA. Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. Clin Gerontol. 1986.\u00a0https:\/\/doi.org\/10.1300\/J018v05n01_09.","DOI":"10.1300\/J018v05n01_09"},{"issue":"2","key":"697_CR43","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0165-1781(91)90040-v","volume":"38","author":"RS Marin","year":"1991","unstructured":"Marin RS, Biedrzycki RC, Firinciogullari S. Reliability and validity of the Apathy Evaluation Scale. Psychiatry Res. 1991;38(2):143\u201362. https:\/\/doi.org\/10.1016\/0165-1781(91)90040-v.","journal-title":"Psychiatry Res"},{"issue":"S5","key":"697_CR44","doi-asserted-by":"publisher","first-page":"e047483","DOI":"10.1002\/alz.047483","volume":"16","author":"B Rizvi","year":"2020","unstructured":"Rizvi B, Lao PJ, Brickman AM. Blood pressure is associated with tau pathology independent of beta-amyloid. Alzheimers Dement. 2020;16(S5):e047483. https:\/\/doi.org\/10.1002\/alz.047483.","journal-title":"Alzheimers Dement"},{"issue":"17","key":"697_CR45","doi-asserted-by":"publisher","first-page":"e1793","DOI":"10.1212\/WNL.0000000000009315.PMC7274847","volume":"94","author":"DZ Carvalho","year":"2020","unstructured":"Carvalho DZ, St Louis EK, Schwarz CG, et al. Witnessed apneas are associated with elevated tau-PET levels in cognitively unimpaired elderly. Neurology. 2020;94(17):e1793\u2013802. https:\/\/doi.org\/10.1212\/WNL.0000000000009315.PMC7274847.","journal-title":"Neurology"},{"key":"697_CR46","doi-asserted-by":"publisher","unstructured":"Martyr A, Clare L. Executive function and activities of daily living in Alzheimer\u2019s disease: a correlational meta-analysis. Dement Geriatr Cogn Disord. 2012;33(2\u20133):189\u2013203. https:\/\/doi.org\/10.1159\/000338233.","DOI":"10.1159\/000338233"},{"issue":"6","key":"697_CR47","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1212\/CON.0000000000001009","volume":"27","author":"DT Jones","year":"2021","unstructured":"Jones DT, Graff-Radford J. Executive Dysfunction and the Prefrontal Cortex. Continuum (Minneap Minn). 2021;27(6):1586\u2013601. https:\/\/doi.org\/10.1212\/CON.0000000000001009.","journal-title":"Continuum (Minneap Minn)"},{"key":"697_CR48","doi-asserted-by":"publisher","unstructured":"Alosco ML, Mian AZ, Buch K, et al. Structural MRI profiles and tau correlates of atrophy in autopsy-confirmed CTE. Alzheimers Res Ther. Dec 7 2021;13(1):193. https:\/\/doi.org\/10.1186\/s13195-021-00928-y. PMC8653514","DOI":"10.1186\/s13195-021-00928-y"},{"key":"697_CR49","doi-asserted-by":"publisher","first-page":"102025","DOI":"10.1016\/j.nicl.2019.102025.PMC6831941","volume":"24","author":"OH Lesman-Segev","year":"2019","unstructured":"Lesman-Segev OH, La Joie R, Stephens ML, et al. Tau PET and multimodal brain imaging in patients at risk for chronic traumatic encephalopathy. Neuroimage Clin. 2019;24:102025. https:\/\/doi.org\/10.1016\/j.nicl.2019.102025.PMC6831941.","journal-title":"Neuroimage Clin"},{"key":"697_CR50","doi-asserted-by":"publisher","unstructured":"Alosco ML, Su Y, Stein TD, et al. Associations between near end-of-life flortaucipir PET and postmortem CTE-related tau neuropathology in six former American football players. Eur J Nucl Med Mol Imaging. 2022;https:\/\/doi.org\/10.1007\/s00259-022-05963-x.","DOI":"10.1007\/s00259-022-05963-x"},{"issue":"3","key":"697_CR51","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s11682-018-9895-z.PMC6854905","volume":"13","author":"C Lepage","year":"2019","unstructured":"Lepage C, Muehlmann M, Tripodis Y, et al. Limbic system structure volumes and associated neurocognitive functioning in former NFL players. Brain Imaging Behav. 2019;13(3):725\u201334. https:\/\/doi.org\/10.1007\/s11682-018-9895-z.PMC6854905.","journal-title":"Brain Imaging Behav"},{"issue":"18","key":"697_CR52","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1056\/NEJMoa1900757.PMC6636818","volume":"380","author":"RA Stern","year":"2019","unstructured":"Stern RA, Adler CH, Chen K, et al. Tau Positron-Emission Tomography in Former National Football League Players. N Engl J Med. 2019;380(18):1716\u201325. https:\/\/doi.org\/10.1056\/NEJMoa1900757.PMC6636818.","journal-title":"N Engl J Med"},{"issue":"5","key":"697_CR53","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/s41591-021-01309-6.PMC8686688","volume":"27","author":"JW Vogel","year":"2021","unstructured":"Vogel JW, Young AL, Oxtoby NP, et al. Four distinct trajectories of tau deposition identified in Alzheimer\u2019s disease. Nat Med. 2021;27(5):871\u201381. https:\/\/doi.org\/10.1038\/s41591-021-01309-6.PMC8686688.","journal-title":"Nat Med."},{"key":"697_CR54","doi-asserted-by":"publisher","unstructured":"Poulin SP, Dautoff R, Morris JC, Barrett LF, Dickerson BC, Alzheimer's Disease Neuroimaging I. Amygdala atrophy is prominent in early Alzheimer's disease and relates to symptom severity. Psychiatry Res. 2011;194(1):7\u201313. https:\/\/doi.org\/10.1016\/j.pscychresns.2011.06.014. PMC3185127.","DOI":"10.1016\/j.pscychresns.2011.06.014"},{"issue":"1","key":"697_CR55","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13024-021-00456-1","volume":"16","author":"Y Chen","year":"2021","unstructured":"Chen Y, Dang M, Zhang Z. Brain mechanisms underlying neuropsychiatric symptoms in Alzheimer\u2019s disease: a systematic review of symptom-general and -specific lesion patterns. Mol Neurodegener. 2021;16(1):38. https:\/\/doi.org\/10.1186\/s13024-021-00456-1.","journal-title":"Mol Neurodegener."},{"key":"697_CR56","doi-asserted-by":"publisher","first-page":"679984","DOI":"10.3389\/fneur.2021.679984","volume":"12","author":"A Jaramillo-Jimenez","year":"2021","unstructured":"Jaramillo-Jimenez A, Giil LM, Tovar-Rios DA, et al. Association Between Amygdala Volume and Trajectories of Neuropsychiatric Symptoms in Alzheimer\u2019s Disease and Dementia With Lewy Bodies. Front Neurol. 2021;12:679984.","journal-title":"Front Neurol."},{"key":"697_CR57","doi-asserted-by":"publisher","unstructured":"Alosco M.L. LM, Mosaheb, S, Saltiel N, Uretsky M, Tripodis Y, Martin B, Palmisano J, Delano-Wood L, Bondi M.W., Meng G, Xia W, Daley S, Goldstein L.E., Katz D.I., Dwyer B, Daneshvar D.H., Nowinski C, Cantu R.C., Kowall N.W., Stern R.A., Alvarez V.E., Mez J, Huber B.R., McKee A.C., Stein T.D. Decreased myelin proteins in brain donors exposed to football-related repetitive head impacts. Brain Commun.\u00a0https:\/\/doi.org\/10.1093\/braincomms\/fcad019.","DOI":"10.1093\/braincomms\/fcad019"},{"issue":"3","key":"697_CR58","doi-asserted-by":"publisher","first-page":"e223299","DOI":"10.1001\/jamanetworkopen.2022.3299","volume":"5","author":"AL Roberts","year":"2022","unstructured":"Roberts AL, Zafonte R, Chibnik LB, et al. Association of Adverse Childhood Experiences With Poor Neuropsychiatric Health and Dementia Among Former Professional US Football Players. JAMA Netw Open. 2022;5(3):e223299. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.3299.","journal-title":"JAMA Netw Open."},{"issue":"6","key":"697_CR59","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1162\/jocn.2006.18.6.871","volume":"18","author":"JS Beer","year":"2006","unstructured":"Beer JS, John OP, Scabini D, Knight RT. Orbitofrontal cortex and social behavior: integrating self-monitoring and emotion-cognition interactions. J Cogn Neurosci. 2006;18(6):871\u20139. https:\/\/doi.org\/10.1162\/jocn.2006.18.6.871.","journal-title":"J Cogn Neurosci"},{"key":"697_CR60","doi-asserted-by":"publisher","unstructured":"Finger E, Zhang J, Dickerson B, Bureau Y, Masellis M, Alzheimer's Disease Neuroimaging I. Disinhibition in Alzheimer's Disease is Associated with Reduced Right Frontal Pole Cortical Thickness. J Alzheimers Dis. 2017;60(3):1161\u20131170. https:\/\/doi.org\/10.3233\/JAD-170348.","DOI":"10.3233\/JAD-170348"},{"issue":"Pt 9","key":"697_CR61","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1093\/brain\/awr173","volume":"134","author":"M Hornberger","year":"2011","unstructured":"Hornberger M, Geng J, Hodges JR. Convergent grey and white matter evidence of orbitofrontal cortex changes related to disinhibition in behavioural variant frontotemporal dementia. Brain. 2011;134(Pt 9):2502\u201312. https:\/\/doi.org\/10.1093\/brain\/awr173.","journal-title":"Brain"},{"key":"697_CR62","doi-asserted-by":"publisher","unstructured":"Cajanus A, Solje E, Koikkalainen J, et al. The Association Between Distinct Frontal Brain Volumes and Behavioral Symptoms in Mild Cognitive Impairment, Alzheimer\u2019s Disease, and Frontotemporal Dementia. Front Neurol. 2019;10:1059. https:\/\/doi.org\/10.3389\/fneur.2019.01059.PMC6786130.","DOI":"10.3389\/fneur.2019.01059.PMC6786130"},{"issue":"2","key":"697_CR63","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1089\/neu.2016.4413.PMC5220530","volume":"34","author":"PH Montenigro","year":"2017","unstructured":"Montenigro PH, Alosco ML, Martin BM, et al. Cumulative Head Impact Exposure Predicts Later-Life Depression, Apathy, Executive Dysfunction, and Cognitive Impairment in Former High School and College Football Players. J Neurotrauma. 2017;34(2):328\u201340. https:\/\/doi.org\/10.1089\/neu.2016.4413.PMC5220530.","journal-title":"J Neurotrauma"},{"issue":"14","key":"697_CR64","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1089\/neu.2012.2690.PMC3713446","volume":"30","author":"DR Seichepine","year":"2013","unstructured":"Seichepine DR, Stamm JM, Daneshvar DH, et al. Profile of self-reported problems with executive functioning in college and professional football players. J Neurotrauma. 2013;30(14):1299\u2013304. https:\/\/doi.org\/10.1089\/neu.2012.2690.PMC3713446.","journal-title":"J Neurotrauma"},{"issue":"1","key":"697_CR65","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/ana.25123.PMC5876116","volume":"83","author":"PA Boyle","year":"2018","unstructured":"Boyle PA, Yu L, Wilson RS, Leurgans SE, Schneider JA, Bennett DA. Person-specific contribution of neuropathologies to cognitive loss in old age. Ann Neurol. 2018;83(1):74\u201383. https:\/\/doi.org\/10.1002\/ana.25123.PMC5876116.","journal-title":"Ann Neurol"},{"issue":"9","key":"697_CR66","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1093\/jnen\/nly065.PMC6097837","volume":"77","author":"JW Adams","year":"2018","unstructured":"Adams JW, Alvarez VE, Mez J, et al. Lewy Body Pathology and Chronic Traumatic Encephalopathy Associated With Contact Sports. J Neuropathol Exp Neurol. 2018;77(9):757\u201368. https:\/\/doi.org\/10.1093\/jnen\/nly065.PMC6097837.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"12","key":"697_CR67","doi-asserted-by":"publisher","first-page":"e2138801","DOI":"10.1001\/jamanetworkopen.2021.38801","volume":"4","author":"DH Daneshvar","year":"2021","unstructured":"Daneshvar DH, Mez J, Alosco ML, et al. Incidence of and Mortality From Amyotrophic Lateral Sclerosis in National Football League Athletes. JAMA Netw Open. 2021;4(12):e2138801. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.38801.","journal-title":"JAMA Netw Open."},{"issue":"1","key":"697_CR68","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13195-019-0471-6","volume":"11","author":"OA Halawa","year":"2019","unstructured":"Halawa OA, Gatchel JR, Amariglio RE, et al. Inferior and medial temporal tau and cortical amyloid are associated with daily functional impairment in Alzheimer\u2019s disease. Alzheimers Res Ther. 2019;11(1):14. https:\/\/doi.org\/10.1186\/s13195-019-0471-6.","journal-title":"Alzheimers Res Ther."},{"issue":"8","key":"697_CR69","doi-asserted-by":"publisher","first-page":"6948","DOI":"10.1111\/ejn.15045.PMC8121900","volume":"54","author":"T James","year":"2021","unstructured":"James T, Kula B, Choi S, Khan SS, Bekar LK, Smith NA. Locus coeruleus in memory formation and Alzheimer\u2019s disease. Eur J Neurosci. 2021;54(8):6948\u201359. https:\/\/doi.org\/10.1111\/ejn.15045.PMC8121900.","journal-title":"Eur J Neurosci"},{"issue":"1","key":"697_CR70","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1001\/archpsyc.56.1.45","volume":"56","author":"WJ Hoogendijk","year":"1999","unstructured":"Hoogendijk WJ, Sommer IE, Pool CW, et al. Lack of association between depression and loss of neurons in the locus coeruleus in Alzheimer disease. Arch Gen Psychiatry. 1999;56(1):45\u201351. https:\/\/doi.org\/10.1001\/archpsyc.56.1.45.","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"697_CR71","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/s41386-022-01293-6.PMC8938499","volume":"47","author":"CM Cassidy","year":"2022","unstructured":"Cassidy CM, Therriault J, Pascoal TA, et al. Association of locus coeruleus integrity with Braak stage and neuropsychiatric symptom severity in Alzheimer\u2019s disease. Neuropsychopharmacology. 2022;47(5):1128\u201336. https:\/\/doi.org\/10.1038\/s41386-022-01293-6.PMC8938499.","journal-title":"Neuropsychopharmacology."},{"issue":"4","key":"697_CR72","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1093\/brain\/awab405.PMC9128811","volume":"145","author":"E Duzel","year":"2022","unstructured":"Duzel E, Ziegler G, Berron D, et al. Amyloid pathology but not APOE epsilon4 status is permissive for tau-related hippocampal dysfunction. Brain. 2022;145(4):1473\u201385. https:\/\/doi.org\/10.1093\/brain\/awab405.PMC9128811.","journal-title":"Brain"},{"issue":"9","key":"697_CR73","doi-asserted-by":"publisher","first-page":"e859","DOI":"10.1212\/WNL.0000000000006075.PMC6133625","volume":"91","author":"AJ Aschenbrenner","year":"2018","unstructured":"Aschenbrenner AJ, Gordon BA, Benzinger TLS, Morris JC, Hassenstab JJ. Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease. Neurology. 2018;91(9):e859\u201366. https:\/\/doi.org\/10.1212\/WNL.0000000000006075.PMC6133625.","journal-title":"Neurology"},{"issue":"20","key":"697_CR74","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1089\/neu.2019.6398","volume":"36","author":"DK Schneider","year":"2019","unstructured":"Schneider DK, Galloway R, Bazarian JJ, et al. Diffusion Tensor Imaging in Athletes Sustaining Repetitive Head Impacts: A Systematic Review of Prospective Studies. J Neurotrauma. 2019;36(20):2831\u201349. https:\/\/doi.org\/10.1089\/neu.2019.6398.","journal-title":"J Neurotrauma"},{"issue":"1","key":"697_CR75","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1212\/WNL.0000000000013012.PMC8726571","volume":"98","author":"M Uretsky","year":"2022","unstructured":"Uretsky M, Bouix S, Killiany RJ, et al. Association Between Antemortem FLAIR White Matter Hyperintensities and Neuropathology in Brain Donors Exposed to Repetitive Head Impacts. Neurology. 2022;98(1):e27\u201339. https:\/\/doi.org\/10.1212\/WNL.0000000000013012.PMC8726571.","journal-title":"Neurology"},{"key":"697_CR76","doi-asserted-by":"publisher","unstructured":"Alosco ML, Tripodis Y, Baucom ZH, et al. White matter hyperintensities in former American football players. Alzheimers Dement. 2022;https:\/\/doi.org\/10.1002\/alz.12779.","DOI":"10.1002\/alz.12779"},{"issue":"8","key":"697_CR77","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1093\/aje\/kwac075","volume":"191","author":"J LeClair","year":"2022","unstructured":"LeClair J, Weuve J, Fox MP, et al. Relationship Between Level of American Football Playing and Diagnosis of Chronic Traumatic Encephalopathy in a Selection Bias Analysis. Am J Epidemiol. 2022;191(8):1429\u201343. https:\/\/doi.org\/10.1093\/aje\/kwac075.","journal-title":"Am J Epidemiol"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-023-00697-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-023-00697-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-023-00697-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T20:02:40Z","timestamp":1707163360000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-023-00697-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,6]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["697"],"URL":"https:\/\/doi.org\/10.1186\/s13024-023-00697-2","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,6]]},"assertion":[{"value":"19 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional review board (IRB) approval for brain donation, post-mortem clinical record review, interviews with informants, and neuropathological evaluation were obtained through the Boston University Medical Campus (BUMC) IRB. Informed consent for brain donation and study enrollment was obtained from the brain donors\u2019 next-of-kin.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Goldstein is a paid consultant to Johnson & Johnson, Janssen Research & Development LLC, and Rebiscan Inc and has received funding from the WWE (World Wrestling Entertainment) and Ivivi Health Sciences.Dr. Nowinski is the Co-Founder and Chief Executive Officer of the Concussion Legacy Foundation, and serves as an advisor for Oxeia Biopharmaceuticals and PreCon Health, Inc.Dr. Stern is a paid consultant to Biogen, is a member of the Mackey-White Health and Safety Committee of the National Football League Players Association, receives royalties for published neuropsychological tests from Psychological Assessment Resources Inc, is a member of the Board of Directors of King-Devick Technologies, and reported grants from the National Institutes of Health during the conduct of the study.Dr. Cantu is a paid consultant to the National Football League Head Neck and Spine Committee, a vice president and chair of the scientific advisory committee of the National Operating Committee on Standards for Athletic Equipment, and a consultant to the Concussion Legacy Foundation; he also receives royalties from Houghton Mifflin Harcourt and compensation for expert legal opinion to the National Collegiate Athletic Association and National Hockey League and is a member of the Mackey-White Committee of the National Football League Players Association.Dr. McKee is a member of the Mackey-White Committee of the National Football League Players Association and reports receiving grants from the National Institutes of Health and Department of Veteran Affairs and other funding from Buoniconti Foundation during the conduct of the study.Dr. Alosco reported grants from National Institutes of Health during the conduct of the study.Dr. Katz reported grants from Boston University School of Medicine Department of Neurology during the conduct of the study, receives royalties from Springer\/Demos Publishing for a text book on brain injury, serves as an expert witness in legal cases involving brain injury and concussion; receives a stipend from Encompass Health as program medical director for brain injury and chair of the annual Neurorehabilitation conference; has received honoraria for a keynote address for the HealthSouth annual Medical Directors meeting.Dr. Mez reported grants from the National Institutes of Health, Department of Defense, Alzheimer\u2019s Association, and Concussion Legacy Foundation during the conduct of the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}